PIM-3 kinase as a target for type 2 diabetes mellitus

Details for Australian Patent Application No. 2003202579 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Mueller, Guenter; Tschank, Georg; Korn, Marcus; Schneider, Rudolf

Agent Watermark

Pub. Number AU-B-2003202579

PCT Number PCT/EP03/00492

PCT Pub. Number WO2003/060130

Priority 02001401.5 19.01.02 EP

Filing date 20 January 2003

Wipo publication date 30 July 2003

Acceptance publication date 3 May 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/45 (2006.01) Medicinal preparations containing peptides

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/54 (2006.01) Mutation or genetic engineering - Transferases (2)

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 02001401.5 19.01.02 EP

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2003202579

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

3 May 2007 Application Accepted

  Published as AU-B-2003202579

30 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003202580-Amidoacetonitrile derivatives

2003202578-LIGHTING SYSTEM COMPRISING A NESTED COLLECTOR FOR ANNULARLY ILLUMINATING AN EXIT PUPIL